Nachrichten zur Roivant Sciences Ltd. Aktie

2 Nasdaq Stocks That Could Soar This Week

BridgeBio Pharma and Roivant Sciences could make big moves this week....…

Roivant (ROIV) Up on Reports of Colitis Drug Sale to Roche

Roivants (ROIV) RVT-3101, a once-monthly subcutaneously administered anti-TL1A antibody, is being developed for ulcerative colitis and Crohns disease...…

Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal

Roivant Sciences Ltd (NASDAQ: ROIV), a biotech company founded by Vivek Ramaswamy, a Republican presidential candidate, is reportedly in discussions with Roche Holdings…

S&P 500 Futures Climb in Premarket Trading; Elanco Animal Health, Roivant Sciences Lead

S&P 500 Futures Climb in Premarket Trading; Elanco Animal Health, Roivant Sciences Lead...…

WSJ: Roche wohl an Milliarden-Deal für Magenmittel interessiert

Wie das "Wall Street Journal" (WSJ) berichtet, führt der Basler Konzern derzeit mit dem US-Biotechunternehmen Roivant Gespräche über den Kauf…

Acadia stock rallies on drug news as Roivant also climbs, while Leslie’s, Theseus shares plunge and more moving stocks

Acadia Pharmaceuticals, Roivant, Leslie's, Nokia and Ericsson were among the biggest moving shares ahead of Friday's market open....…

JPMorgan, Citigroup, Wells Fargo, UnitedHealth, Roivant, and More Stock Market Movers

JPMorgan Chase, Wells Fargo, and Citigroup are scheduled to report earnings Friday, as are UnitedHealth and BlackRock. Shares of both…

Roivant in Talks to Sell Stomach Drug to Roche in Deal Valued at More Than $7 Billion

Roivant, started by presidential candidate Vivek Ramaswamy, could seal a deal in coming days....…

Ankündigung wohl in den kommenden Tagen: Roche soll an einem Milliarden-Deal für Magenmittel arbeiten

Pharmakonzern - Der Pharmakonzern Roche führt derzeit Gespräche mit dem US-Biotechunternehmen Roivant über den Kauf eines experimentellen Magenmittels. Kosten: Bis…

Biotech-Aktie schießt 20 Prozent hoch – das ist der Grund

Der Pharmakonzern Roche könnte schon in den kommenden Tagen über einen Milliarden-Deal informieren. Wie das "Wall Street Journal" berichtet, führt…

Roche verhandelt wohl über Medikament-Kauf für 7 Milliarden Dollar

Das Basler Unternehmen Roivant will offenbar ein Darm-Medikament an Roche für 7 Milliarden Dollar verkaufen....…

Roivant Sciences In Talks To Sell Stomach Drug To Roche In More Than $7 Bln Deal: Report

SOUTH SAN FRANCISCO (dpa-AFX) - Roivant Sciences Ltd. (ROIV) is in talks to sell an experimental drug for a debilitating…

Roivant reportedly could sell colitis drug to Roche for over $7B

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant in talks to sell bowel disease drug to Roche in over $7 billion deal - WSJ

...(Reuters) - Biotech company Roivant Sciences is nearing a deal... not immediately respond to a Reuters…

Roivant stock rallies on report of pending drug sale: WSJ

Shares of Roivant Sciences Ltd. ROIV surged in the extended session Thursday following a report that Roche Holding CH:ROG was…

UPDATE 1-Roivant in talks to sell bowel disease drug to Roche in over $7 bln deal - WSJ

... 2 & 3, details of the drug in paragraphs 4 & 5) July 13 (Reuters... to a Reuters request for…

Roivant in talks to sell stomach disease drug to Roche in over $7 bln deal - WSJ

...July 13 (Reuters) - Biotech company Roivant Sciences is nearing......…

Watch Potential Buyers Looking at Drugmaker Roivant

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Said to Attract Interest for $7 Billion-Plus Bowel Drug

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Sciences garners interest for multi-billion bowel drug - Bloomberg

...(Reuters) - Roivant Sciences Ltd is attracting interest from... at the moment on the matter when…

Roivant Sciences has reportedly drawn $7B+ interest in bowel drug

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Sciences Ltd. (ROIV) Surges 8.9%: Is This an Indication of Further Gains?

Roivant Sciences Ltd. (ROIV) witnessed a jump in share price last session on above-average trading volume. The latest trend in…

Why Shares of Roivant Sciences Rose Wednesday

The pharmaceutical company released fourth-quarter earnings....…

After ‘transformative’ year, Roivant aims to challenge bigger rivals in inflammation and immunology

Roivant shares gain more than 10% after narrower-than-expected quarterly loss....…

Roivant Sciences Ltd. (ROIV) Reports Q4 Loss, Tops Revenue Estimates

Roivant Sciences Ltd. (ROIV) delivered earnings and revenue surprises of 51.22% and 44.56%, respectively, for the quarter ended March 2023.…

Form 8-K/A Roivant Sciences Ltd. For: Jun 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Sciences’ stock up 3.7% premarket after posting narrower-than-expected loss

Roivant Sciences Ltd. ROIV said Wednesday it had a net loss of $33.6 million, or 20 cents a share, for…

Form 10-K Roivant Sciences Ltd. For: Mar 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Form 8-K Roivant Sciences Ltd. For: Jun 28

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provides Business Update

BASEL, Switzerland, and LONDON, and NEW YORK, June 28, 2023 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) today reported…

Roivant Sciences FQ4 2023 Earnings Preview

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Insiderhandel: Insider verkauft Aktien von Roivant Sciences im Wert von 128.700.000$

Viking Global Investors Lp - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-06-22...…

Insiderhandel: Insider verkauft Aktien von Roivant Sciences im Wert von 129.999.982$

Sumitomo Chemical Co., Ltd. - Zehn-Prozent-Eigentümer - Tag der Transaktion: 2023-06-22...…

Roivant to Report Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2023, and Provide Business Update on Wednesday, June 28, 2023

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq:…

Why Roivant Sciences Stock Is Perking Up Today

Positive long-term data for a novel ulcerative colitis medication is fueling a double-digit rise in the drugmakers stock....…

Roivant rises after long-term data for ulcerative colitis candidate

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Roivant Sciences shares gain after ulcerative colitis treatment shows longer-term results

Shares of Roivant Sciences Ltd. ROIV gained 14% in premarket trading Thursday after the company released new long-duration data from…

Roivant Reports Chronic Period Data for RVT-3101 from the TUSCANY-2 Phase 2b Study in Ulcerative Colitis, Demonstrating Improved Efficacy from the Induction to Chronic Period

BASEL, Switzerland and LONDON and NEW YORK and BOSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Roivant Sciences (Nasdaq:…

dpa-AFX ProFeed